Viewing Study NCT03119012

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-03-03 @ 5:04 PM
Study NCT ID: NCT03119012
Status: TERMINATED
Last Update Posted: 2024-04-22
First Post: 2017-04-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
Sponsor: Samsung Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
None Stents View
None Atherosclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioresorbable scaffold View
None Dual antiplatelet therapy View
None P2Y12 receptor inhibitor View
None Coronary artery disease View